RBM appoints new CEO

CEO will lead new team to support attainment of the global goals for malaria

27 Jan 2017

MMV welcomes the appointment of Dr Kesetebirhan Admasu, a medical doctor, public health specialist and former Minister of Health of Ethiopia, as the new CEO of the Roll Back Malaria (RBM) Partnership.

Dr Kesete will officially commence duties on 1 February 2017. He will play a critical role as the global face of the Partnership, including establishing and leading the new team and ensuring that regions and countries are empowered to address the global fight against malaria.

“I am excited to join RBM Partnership as the CEO,” Dr Kesetebirhan Admasu. “I look forward to working with all the RBM partners in the effort to relegate malaria into the history books.”

The RBM Partnership is the global platform, launched in 1998 by WHO, UNICEF, UNDP and the World Bank, for coordinated action against malaria. It mobilizes resources and forges consensus among partners in the malaria field. In 2015, the Partnership underwent a restructuring process to enable it to sustain and build on its successes and help deliver on the ambitious goals outlined in the WHO Global Technical Strategy and accompanying RBM Action and Investment to defeat Malaria (AIM) report.

“We are delighted to hear that Dr Admasu has been appointed to lead the newly re-structured RBM partnership,” said Dr David Reddy, MMV’s CEO and member of RBM’s Board of Directors. “His appointment comes at an important time on the path to defeating malaria. We are 10 years on from the call for eradication and while we have seen much progress since then, much remains to be done. MMV looks forward to working closely with Dr Admasu and the RBM team to contribute to the global malaria eradication goals.”